These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 19749003)
1. Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis. Kosoglou T; Cutler DL; Staudinger H; Herron JM Chest; 2010 Jan; 137(1):115-21. PubMed ID: 19749003 [TBL] [Abstract][Full Text] [Related]
2. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects. Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918 [TBL] [Abstract][Full Text] [Related]
3. Effect of therapeutic doses of mometasone furoate on cortisol levels in children with mild asthma. Skoner DP; Gentile DA; Angelini B Allergy Asthma Proc; 2010; 31(1):10-9. PubMed ID: 20167141 [TBL] [Abstract][Full Text] [Related]
4. Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma. Skoner DP; Meltzer EO; Milgrom H; Stryszak P; Teper A; Staudinger H J Asthma; 2011 Oct; 48(8):848-59. PubMed ID: 21854342 [TBL] [Abstract][Full Text] [Related]
5. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses. Affrime MB; Kosoglou T; Thonoor CM; Flannery BE; Herron JM Chest; 2000 Dec; 118(6):1538-46. PubMed ID: 11115437 [TBL] [Abstract][Full Text] [Related]
6. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler. Kosoglou T; Hubbell J; Cutler DL; Johnson-Levonas AO; Xu D; Kantesaria BS; Kim K; Miller SD Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids. D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538 [TBL] [Abstract][Full Text] [Related]
9. Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma. Karpel JP; Nelson H Curr Med Res Opin; 2007 Nov; 23(11):2897-911. PubMed ID: 17922978 [TBL] [Abstract][Full Text] [Related]
10. Effects of mometasone furoate administered via a dry powder inhaler once daily in the evening on nocturnal lung function and sleep parameters in patients with moderate persistent asthma: a randomized, double-blind, placebo-controlled pilot study. Krouse JH; Krouse HJ; Janisse JJ Clin Drug Investig; 2009; 29(1):51-8. PubMed ID: 19067474 [TBL] [Abstract][Full Text] [Related]
11. Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma. Noonan M; Leflein J; Corren J; Staudinger H BMC Pediatr; 2009 Jul; 9():43. PubMed ID: 19594937 [TBL] [Abstract][Full Text] [Related]
12. Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma. Zeidler M; Corren J; Tashkin DP Curr Med Res Opin; 2010 Jun; 26(6):1295-305. PubMed ID: 20370376 [TBL] [Abstract][Full Text] [Related]
13. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma. Berger WE; Milgrom H; Chervinsky P; Noonan M; Weinstein SF; Lutsky BN; Staudinger H Ann Allergy Asthma Immunol; 2006 Nov; 97(5):672-80. PubMed ID: 17165278 [TBL] [Abstract][Full Text] [Related]
14. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler. Noonan M; Karpel JP; Bensch GW; Ramsdell JW; Webb DR; Nolop KB; Lutsky BN Ann Allergy Asthma Immunol; 2001 Jan; 86(1):36-43. PubMed ID: 11206236 [TBL] [Abstract][Full Text] [Related]
15. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282 [TBL] [Abstract][Full Text] [Related]